Wall Street Analysts Think ANI (ANIP) Is a Good Investment: Is It?
ANI Pharmaceuticals(ANIP) Zacks Investment Research·2024-04-05 22:35券商分析师推荐 - 投资者通常会参考华尔街分析师的推荐来做出股票买入、卖出或持有决策[1] - ANI Pharmaceuticals (ANIP)目前的平均券商推荐（ABR）为1.20，介于强烈买入和买入之间[2] - 当前ABR的五个推荐中，80%为强烈买入，20%为买入[3] - 券商推荐在选择具有最佳价格增长潜力的股票方面成功有限甚至没有成功[4]